Pharmacotherapeutics for Advanced Practice Nurse Prescribers, 6th Edition
ix ix ix ix ix ix ix
Author: Teri Moser Woo and Wendy L. Wright
ix ix ix ix ix ix ix
, TABLE OF CONTENT ix ix
Chapter 1. The Role of the Advanced Practice Nurse as Prescriber ......................................................................... 4
ix ix ix ix ix ix ix ix ix ix
Chapter 2. Review of Basic Principles of Pharmacology ........................................................................................ 5
ix ix ix ix ix ix ix
Chapter 3. Rational Drug Selection ...................................................................................................................... 11
ix ix ix ix
Chapter 4. Legal and Professional Issues in Prescribing ....................................................................................... 14
ix ix ix ix ix ix ix
Chapter 5. Adverse Drug Reactions ..................................................................................................................... 16
ix ix ix ix
Chapter 6. An Introduction to Pharmacogenomics ............................................................................................... 19
ix ix ix ix ix
Chapter 7. Nutrition and Nutraceuticals ............................................................................................................... 22
ix ix ix ix
Chapter 8. Herbal Therapies ................................................................................................................................. 28
ix ix ix
Chapter 9. Cannabis ............................................................................................................................................. 31
ix ix
Chapter 10. Pharmacoeconomics ......................................................................................................................... 35
ix ix
Chapter 11. Drugs Affecting the Autonomic Nervous System ............................................................................. 38
ix ix ix ix ix ix ix
Chapter 12. Drugs Affecting the Central Nervous System .................................................................................... 45
ix ix ix ix ix ix ix
Chapter 13. Drugs Affecting the Cardiovascular and Renal Systems.................................................................... 53
ix ix ix ix ix ix ix ix
Chapter 14. Drugs Affecting the Respiratory System ........................................................................................... 61
ix ix ix ix ix ix
Chapter 15. Drugs Affecting the Hematological System ...................................................................................... 65
ix ix ix ix ix ix
Chapter 16. Drugs Affecting the Immune System: Vaccines and Immunoglobulins ............................................. 69
ix ix ix ix ix ix ix ix ix
Chapter 17. Drugs Affecting the Immune System: Immunomodulators ............................................................... 75
ix ix ix ix ix ix ix
Chapter 18. Drugs Affecting the Gastrointestinal System .................................................................................... 77
ix ix ix ix ix ix
Chapter19. Drugs Affecting the EndocrineSystem: Pancreatic Hormones and Antidiabetic Drugs ....................... 80
ix ix ix ix ix ix ix ix ix ix ix
Chapter 20. Drugs Affecting the Endocrine System: Pituitary, Thyroid, and Adrenal Drugs ................................ 83
ix ix ix ix ix ix ix ix ix ix ix
Chapter 21. Drugs Affecting the Reproductive System ........................................................................................ 86
ix ix ix ix ix ix
Chapter 22. Drugs Affecting the Bones and Joints................................................................................................ 92
ix ix ix ix ix ix ix
Chapter 23. Drugs Affecting the Integumentary System ...................................................................................... 96
ix ix ix ix ix ix
Chapter 24. Drugs Used to Treat Bacterial Infections ......................................................................................... 101
ix ix ix ix ix ix ix
Chapter 25. Drugs Used to Treat Viral, Fungal, and Protozoal Infections ........................................................... 105
ix ix ix ix ix ix ix ix ix ix
Chapter 26. Drugs Used to Treat Inflammatory Processes .................................................................................. 108
ix ix ix ix ix ix ix
Chapter 27. Drugs Used to Treat Eye and Ear Disorders ..................................................................................... 111
ix ix ix ix ix ix ix ix ix
Chapter 28. Anemia ........................................................................................................................................... 113
ix ix
Chapter 29. Anxiety and Depression .................................................................................................................. 116
ix ix ix ix
Chapter 30. Attention Deficit-Hyperactivity Disorder ....................................................................................... 120
ix ix ix ix
Chapter 31. Asthma and Allergy ........................................................................................................................ 122
ix ix ix ix
Chapter 32. Chronic Obstructive Pulmonary Disease ......................................................................................... 125
ix ix ix ix ix
Chapter 33. Contraception ................................................................................................................................. 127
ix ix
Chapter 34. COVID-19: Acute and Chronic ....................................................................................................... 130
ix ix ix ix ix
Chapter 35. Dermatological Conditions ............................................................................................................. 134
ix ix ix
Chapter 36. Diabetes Management .................................................................................................................... 138
ix ix ix
Chapter 37. Gastroesophageal Reflux and Peptic Ulcer Disease ........................................................................ 146
ix ix ix ix ix ix ix
Chapter 38. Headaches....................................................................................................................................... 149
ix ix
Chapter 39. Heart Failure ................................................................................................................................... 153
ix ix ix
Chapter 40. HIV Disease and Acquired Immunodeficiency Syndrome .............................................................. 158
ix ix ix ix ix ix ix
Chapter 41. Menopausal Hormone Therapy....................................................................................................... 161
ix ix ix ix
,Chapter 42. Hyperlipidemia ............................................................................................................................... 164
ix ix
Chapter 43. Hypertension................................................................................................................................... 169
ix ix
Chapter 44. Hyperthyroidism and Hypothyroidism ........................................................................................... 174
ix ix ix ix
Chapter 45. Obesity ........................................................................................................................................... 177
ix ix
Chapter 46. Pain Management: Acute and Chronic Pain .................................................................................... 181
ix ix ix ix ix ix ix
Chapter 47. Pneumonia ...................................................................................................................................... 185
ix ix
Chapter 48. Sexually Transmitted Diseases and Vaginitis .................................................................................. 187
ix ix ix ix ix ix
Chapter 49. Substance Use Disorders ................................................................................................................. 190
ix ix ix ix
Chapter 50. Tuberculosis ................................................................................................................................... 195
ix ix
Chapter51. Upper Respiratory Tract Infection, Pharyngitis, Sinusitis, Otitis Media, and Otitis Externa ............... 197
ix ix ix ix ix ix ix ix ix ix ix ix
Chapter 52. Urinary Tract Infections .................................................................................................................. 200
ix ix ix ix
Chapter 53. Women as Patients .......................................................................................................................... 203
ix ix ix ix
Chapter 54. Men as Patients ............................................................................................................................... 207
ix ix ix ix
Chapter 55. Pediatric Patients............................................................................................................................. 209
ix ix ix
Chapter 57. Geriatric Patients............................................................................................................................. 213
ix ix ix
, Woo 1
PharmacotherapeuticsforAPN Prescribers, 6e ix ix ix ix Ch01
Chapter 1. The Role of the Advanced Practice Nurse as Prescriber
ix ix ix ix ix ix ix ix ix ix
MULTIPLE CHOICE ix
1. Nurse practitioner prescriptive authority is regulated by:
ix ix ix ix ix ix
A. The National Council of State Boards of Nursing
ix ix ix ix ix ix ix
B. The U.S. Drug Enforcement Administration
ix ix ix ix
C. The State Board of Nursing for each state
ix ix ix ix ix ix ix
D. The State Board of Pharmacy ix ix ix ix
ANS: i x C PTS: i x i x 1
2. Thebenefits to thepatient ofhaving an advanced practice registered nurse (APRN) prescriber
ix ix ix ix ix ix ix ix ix ix ix ix ix
ix include:
A. Nurses know more about pharmacology than other prescribers because they takeit
ix ix ix ix ix ix ix ix ix ix ix
both in their basic nursing program and in their APRN program.
ix ix ix ix ix ix ix ix ix ix ix
B. Nurses care for thepatient from a holistic approach and includethe patient in
ix ix ix ix ix ix ix ix ix ix ix ix ix
decision-making regarding their care.
ix ix ix ix
C. APRNs are less likely to prescribe narcotics and other controlledsubstances.
ix ix ix ix ix ix ix ix ix ix
D. APRNs areableto prescribeindependently in all states, whereas aphysician’s
ix ix ix ix ix ix ix ix ix ix ix
assistant needs to have a physician supervising their practice.
ix ix ix ix ix ix ix ix ix
ANS: i x B PTS: i x i x 1
3. Clinical judgment in prescribing includes:
ix ix ix ix
A. Factoring in the cost to the patient of the medication prescribed ix ix ix ix ix ix ix ix ix ix
B. Always prescribing the newest medication available for the diseaseprocess
ix ix ix ix ix ix ix ix ix
C. Handing out drug samples to poor patients ix ix ix ix ix ix
D. Prescribing all generic medications to cutcosts ix ix ix ix ix ix
ANS: i x A PTS: i x i x 1
4. The process for choosing an effective drug for a disorder includes:
ix ix ix ix ix ix ix ix ix ix
A. Asking the patient what drug they think would work best for them
ix ix ix ix ix ix ix ix ix ix ix
B. Consulting nationally recognized guidelines for diseasemanagement ix ix ix ix ix ix
C. Prescribing medications that are available as samples before writing a prescription ix ix ix ix ix ix ix ix ix ix
D. Following U.S. Drug Enforcement Administration guidelines forprescribing ix ix ix ix ix ix ix
ANS: i x B PTS: i x i x 1
5. Nonintentional nonadherence of drug therapy may occur due to: ix ix ix ix ix ix ix ix
A. Belief that medication does not work ix ix ix ix ix
B. Adverse drug reactions ix ix
C. Chronic conditions that require dailytherapy ix ix ix ix ix
D. Forgetfulness ordistraction ix ix
ANS: i x D PTS: i x i x 1